A detailed history of Rpo LLC transactions in Alector, Inc. stock. As of the latest transaction made, Rpo LLC holds 26,395 shares of ALEC stock, worth $49,358. This represents 0.07% of its overall portfolio holdings.

Number of Shares
26,395
Holding current value
$49,358
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$1.72 - $6.06 $45,399 - $159,953
26,395 New
26,395 $49,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Rpo LLC Portfolio

Follow Rpo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rpo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rpo LLC with notifications on news.